PrimeRFP SCOUT · Federal Contract Recompete Brief

VA24717F1275URINE DRUG screening OPTION YEAR FOUR — Quest Diagnostics Inc

Quest Diagnostics Inc holds $202.6M across 1,625 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent V797D70090. Competition previously drew 2 offers. PoP ended Aug 28, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

247-Network Contract Office 7 (36C247)

Awarding office

Quest Diagnostics Inc

Recipient

Aug 28, 2022

PoP end

$-193,475.7

Obligated

$4.7M

Potential

621511

NAICS

Q301

PSC

2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract numberVA24717F1275

Also listed asVA247-17-F-1275

Also listed asV797D70090-VA24717F1275

Agency247-Network Contract Office 7 (36C247)

Awarding office247-Network Contract Office 7 (36C247)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentQuest Diagnostics Inc

CAGE1FHB9

UEIUC5SPMUJF8V3

NAICS621511

No full NAICS 621511 intel page yet. Browse NAICS intelligence

PSCQ301

Parent IDIQ / IDVV797D70090

Place of performanceCOLUMBIA SC

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startMay 1, 2017

PoP end (current)Aug 28, 2022

Obligated$-193,475.7

Current value$4.7M

Potential value$4.7M

URINE DRUG SCREENING OPTION YEAR FOUR is a federal award for 247-Network Contract Office 7 (36C247) held by Quest Diagnostics Inc. Estimated value $4.7M ($-193,475.7 obligated). Current period of performance ends Aug 28, 2022. Last award drew 2 bidders. Place of performance: COLUMBIA SC.

Recompete timing

Public

● Past PoP end (1495 days ago)

Current PoP ended Aug 28, 2022 (1495 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on VA24717F1275? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Quest Diagnostics Inc — $202.6M obligated across 1,625 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($202.6M) · all agencies

Department of Veterans Affairs (VA)$282.5M · 139%Department of Justice (DOJ)$30.6M · 15%Department of Defense (DOD)$638K · 0%Department of the Interior (DOI)$81K · 0%

Open full company profile →

Related awards

Same parent · incumbent

36C24125P0577

PRIMARY REFERENCE LABORATORY TESTING / COURIER SERVICES / PHLEBOTOMY

$8.5M

Sep 30, 2026

36C24826N0043

REFERENCE LAB TESTS

$2.7M

Sep 30, 2026

36C24526F0012

LAB TESTING FOR PATIENTS

$2.7M

Sep 30, 2026

36C25226N0411

REFERENCE LAB TESTING - ADD AND EXERCISE OPTION

$2.6M

Sep 30, 2026

36C24526F0014

TESTING FOR PATIENTS

$2.1M

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract VA24717F1275?

VA24717F1275 (URINE DRUG screening OPTION YEAR FOUR) is a 247-Network Contract Office 7 (36C247) award with a potential value of $4.7M, currently held by Quest Diagnostics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is VA247-17-F-1275?

VA247-17-F-1275 is the dashed form of PIID VA24717F1275 (URINE DRUG screening OPTION YEAR FOUR), held by Quest Diagnostics Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded VA24717F1275?

247-Network Contract Office 7 (36C247) awarded VA24717F1275 to Quest Diagnostics Inc (potential $4.7M).

Who is the incumbent on VA24717F1275?

Quest Diagnostics Inc is the incumbent with $202.6M across 1625 related awards in SCOUT’s public footprint. The current period of performance ends Aug 28, 2022.

When does Quest Diagnostics Inc’s VA24717F1275 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 28, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on VA24717F1275? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 1, 2026 · refreshed monthlyLatest procurement action Jul 18, 2022